HTPEP-001, a new drug being developed by the company, was once again recognized by the international authoritative academic conference
MORE >
IPF International Symposium is an annual conference held by the company around the IPF project and the latest progress in the global IPF research field, focusing on the non clinical research frontier ...
MORE >
Chengdu Huitai Biomedicine Company (referred to as "Huitai") successfully held the company's first idiopathic pulmonary fibrosis (IPF) expert Academic conference in Chengdu High-tech Zone, on November...
MORE >
On June 30, 2018, Chengdu Huitai Biomedicine Company held the second corporate sodality - "Listening Summer".
2018-07-04 MORE >
In order to improve the working passion of employees, further strengthen the communication and exchange between employees, and deepen the friendship among colleagues, the company encourages all employ...
2017-04-01 MORE >
